Skip to content

To assess the role of snehapana and virechana in dyslipidemia

Comparative clinical study to evaluate two different modalities of Shodhananga snehapana with Murchita tila taila and Varunadi ghrita followed by Virechana in dyslipidaemia - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089422
Enrollment
100
Registered
2025-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Sponsors

DrSuma S Sadar Joshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BMI Range from 18.5 to 34.9 will be taken for the study • Subjects with borderline high and high as per the NCEP ATP III criteria • Subjects fit for Virechana • Subjects between 30 to 60yrs of age

Exclusion criteria

Exclusion criteria: Having associated disorders like Diabetes Hypothyroidism Nephrotic syndrome Obstructive liver disease Chronic renal failure Drugs, that may raise LDL cholesterol or cause another dyslipidaemia

Design outcomes

Primary

MeasureTime frame
Studies have shown normalcy of the lipid profileTimepoint: Baseline, Day 11, Day 16 and Day24

Secondary

MeasureTime frame
Lipid profile may come normalTimepoint: Before and after the study

Countries

India

Contacts

Public ContactDrSuma S Sadar Joshi

SDM College of Ayurveda and Hospital, Hassan

sumamaski@gmail.com9449515046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026